MEDSECUREAN.COM

Registrant on federal lobbying filings · filed 2025 to 2026

$1,277,000 Income reported

2 Clients represented

11 Filings counted

0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. 2 filings on this record were restated by a later amendment and are left out of every total here. Everything on this page is grouped by the registrant's LDA id (401108536), not by name.

Clients 2

INDIAN PHARMACEUTICAL ALLIANCE(FORMERLY INDIAN PHARMACEUTICAL ASSOCIATION) $1,125,000 6 filings
LUPIN PHARMACEUTICALS $152,000 5 filings

Reported by year 2 years

2026 $276,000 4 filings
2025 $1,001,000 7 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 15

Health & Human Services, Dept of (HHS) 10
SENATE 10
White House Office 10
Commerce, Dept of (DOC) 9
State, Dept of (DOS) 9
U.S. Trade Representative (USTR) 9
HOUSE OF REPRESENTATIVES 6
Food & Drug Administration (FDA) 5
Federal Trade Commission (FTC) 4
Natl Economic Council (NEC) 4
Natl Security Council (NSC) 4
Office of Management & Budget (OMB) 4
Treasury, Dept of 4
Centers For Medicare and Medicaid Services (CMS) 2
Bureau of Industry and Security (BIS) 1

Recent filings 13 total

2A

INDIAN PHARMACEUTICAL ALLIANCE(FORMERLY INDIAN PHARMACEUTICAL ASSOCIATION)

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $90,000 income · posted Jul 13, 2026

View → 1A

INDIAN PHARMACEUTICAL ALLIANCE(FORMERLY INDIAN PHARMACEUTICAL ASSOCIATION)

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $90,000 income · posted Jul 13, 2026

View → Q2

LUPIN PHARMACEUTICALS

2nd Quarter (Apr 1 - June 30) 2026 · Senate · $54,000 income · posted Jul 13, 2026

View → Q1

LUPIN PHARMACEUTICALS

1st Quarter (Jan 1 - Mar 31) 2026 · Senate · $42,000 income · posted Jul 13, 2026

View → Q2

INDIAN PHARMACEUTICAL ALLIANCE(FORMERLY INDIAN PHARMACEUTICAL ASSOCIATION) Amended

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $900,000 income · posted Jul 13, 2026

View → Q1

INDIAN PHARMACEUTICAL ALLIANCE(FORMERLY INDIAN PHARMACEUTICAL ASSOCIATION) Amended

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $900,000 income · posted Jul 13, 2026

View → Q4

LUPIN PHARMACEUTICALS

4th Quarter (Oct 1 - Dec 31) 2025 · Senate · $42,000 income · posted Feb 14, 2026

View → Q4

INDIAN PHARMACEUTICAL ALLIANCE(FORMERLY INDIAN PHARMACEUTICAL ASSOCIATION)

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $900,000 income · posted Feb 14, 2026

View → Q3

LUPIN PHARMACEUTICALS

3rd Quarter (July 1 - Sep 30) 2025 · Senate · $14,000 income · posted Sep 22, 2025

View → Q3

INDIAN PHARMACEUTICAL ALLIANCE(FORMERLY INDIAN PHARMACEUTICAL ASSOCIATION)

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $15,000 income · posted Sep 21, 2025

View → RR

LUPIN PHARMACEUTICALS

1st Quarter (Jan 1 - Mar 31) 2025 · posted Sep 21, 2025

View → Q2

INDIAN PHARMACEUTICAL ALLIANCE(FORMERLY INDIAN PHARMACEUTICAL ASSOCIATION)

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $15,000 income · posted Sep 21, 2025

View → Q1

INDIAN PHARMACEUTICAL ALLIANCE(FORMERLY INDIAN PHARMACEUTICAL ASSOCIATION)

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $15,000 income · posted Mar 5, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.